Dss Score News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innodem Neurosciences, a leading digital health and AI company, announced today that its ETNA™-MS has been cleared for commercial use by Health Canada. The Eye Tracking Neurological Assessment for Multiple Sclerosis (ETNA™-MS) is a software as a medical device (SaMD, Class II) intended to administer a non-invasive test and provide an Expanded Disability Status Scale (EDSS) score in the range between 1.0 and 4.5 for use in tracking disease progression in MS patients. ....

Innodem Neurosciences , Marc Reeves , Erin Keith , Novartis Pharmaceuticals Canada Inc , Neuroscience At Novartis Pharmaceuticals Canada Inc , Pad Pro , Chief Business Officer , Chief Executive Officer , Novartis Pharmaceuticals Canada , Vice President , Eye Tracking Neurological Assessment , Eye Movement , Medical Device , Health Canada , Dss Score , I Company , Neurological Assessment , Ovartis Pharmaceuticals Canada Inc , Digital Health ,